Safety concerns with the long-term management of osteoporosis

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.4, 2013-07, pp. : 507-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis

By Lewiecki E. Michael

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 791-814

Adis International

Access to resources Recommend Favorite

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Safety of Bisphosphonate Therapy for Osteoporosis: A Review of the Evidence

By Liberman Uri A.

Drugs & Aging, Vol. 23, Iss. 4, 2006-01 ,pp. : 289-298

Adis International

Access to resources Recommend Favorite

Long-term safety of ustekinumab for psoriasis

By Kumar Neal Narang Kirti Cressey Brienne D Gottlieb Alice B

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 757-765

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety of tacrolimus ointment in atopic dermatitis

By Remitz Anita Reitamo Sakari

Expert Opinion on Drug Safety, Vol. 8, Iss. 4, 2009-07 ,pp. : 501-506

Informa Healthcare

Access to resources Recommend Favorite